
Ubi-Media 2026 Special Session on Advanced AOI Techniques
(SS_AAOI 2026)
Organizers
Session Chair: Dr. Shih-Yu Chen
National Yunlin University of Science and Technology
Important data
Paper Submission Due: Oct. 15, 2025, Oct. 30, 2025
Notification of Acceptance: Nov. 15, 2025
Camera-Ready Copies Due: Nov. 25, 2025
Early Registration Due: Dec. 15, 2025
Session Date: One day during Jan. 19-20, 2026
Abstract
Recent advances in deep learning, hyperspectral & multispectral sensing, and edge computing have accelerated Automated Optical Inspection (AOI) well beyond factory floors. This Special Session welcomes work that pushes AOI from algorithmic innovation to robust, validated systems — across industrial quality control, food & agriculture, and clinical/medical use-cases. We emphasize papers that address real-world constraints: sensor calibration, lighting, limited labels (few-shot), real-time edge inference, multimodal fusion (RGB + spectral + depth), deployment case studies, and clinical validation pathways including ethics and regulatory considerations. Submissions describing prototypes, pilot clinical studies, production-line integrations, datasets, or reproducible benchmarks are especially encouraged. Our goal is to foster cross-disciplinary exchange between imaging engineers, AI researchers, clinicians, and industry practitioners to accelerate safe and measurable impact.
Scope & Topics of Interest includes —but not limited to:
Deep-learning architectures for defect / lesion detection (2D, 3D, temporal)
Hyperspectral / multispectral imaging applications (band selection, spectral–spatial fusion)
Snapshot vs line-scan tradeoffs for real-time imaging (industrial & clinical form-factors)
Few-shot, semi-/unsupervised, anomaly detection approaches for low-label regimes
Edge inference, quantization, hardware acceleration (embedded platforms, FPGA, TPU)
Multimodal fusion: RGB + spectral + depth + thermal + fluorescence + OCT
Imaging calibration, illumination design, cross-site standardization procedures
Clinical validation & trial design, IRB/ethics reporting, patient privacy & consent practices
Regulatory & quality-management considerations (FDA/CE pathways, risk analysis)
Case studies: production-line integration, intraoperative guidance, endoscopy, dermatology, digital pathology
Dataset creation, annotation protocols, benchmark tasks, reproducibility resources










